Anti Obesity Drugs Market is estimated to grow at a CAGR of 40% during the period 2015-2020, According to Research Nester

Anti-obesity drugs are used to control body weight either by reducing appetite or absorption of calories.

The global anti-obesity drug market is anticipated to grow at compound annual growth rate (CAGR) of 40.0 percent over the period of 2015-2020. Geographically, the global anti-obesity drug market is segmented into North America, Latin America, Western and Eastern Europe, Asia-Pacific and Rest of World.

Request For Sample Pages: https://www.researchnester.com/sample-request/2/rep-id-23

Market Segmentation
By Product Type
Based on product type, the global anti-obesity drug market divided into two types:
Peripherally acting anti-obesity agents
Centrally acting anti-obesity drugs
By Type
Prescription Drugs
Over-the-Counter Drugs
By End User
Based on end user, the global anti-obesity drug market is segmented as:
Hospitals
Vendors

Growth Drivers and challenges

Prevailed bad eating habits, steep growth in packaged food consumption, less physical activity and hereditary concerns are the biggest factor in the increased obese people. Rising concern of health problems related to obesity, presence of large numbers of obese people around the globe and change in lifestyle are the major growth drivers of global anti-obesity drug market.
Global anti-obesity drug market faces some of major challenges like high cost involved in research and development, side effects of anti-obesity drugs, and rising popularities of other alternatives (fitness spas, therapies, etc.) to reduce obesity.

Market Size and Forecast

Regionally, North America anti-obesity drug market is forecasted to have a burgeoned growth during the forecast period i.e. 2015-2021. The market is likely to get propelled owing to rising cases of obesity, expanding healthcare industry and various government initiatives to curb obesity problems.

Request For TOC Here: - https://www.researchnester.com/toc-request/1/rep-id-23

Europe anti-obesity drug market is also expected to witness a steady growth owing to rising cases of diabetes (which is majorly caused due to obesity) in some of the major European countries such as Germany, Spain, Italy, France and the U.K.
Asia-Pacific anti-obesity drug market is anticipated to bolster backed up by improvements in the healthcare sector and increase in disposable income. India and China are two major anti-obesity drug markets in Asia-Pacific region.

Key players
The major players of global anti-obesity drug market are mentioned as below:
Arena Pharmaceuticals Inc.,
F. Hoffmann-La Roche Ag,
GlaxoSmithKline plc,
Takeda Pharmaceuticals Company Limited,
Zafgen,
Zydus Cadila,
Rhythm Pharmaceuticals,
Pfizer Inc.,
Merck & Co. Inc.,
Orexigen Therapeutics Inc.,
Boehringer Ingelheim Gmbh
Eisai Co. Ltd.,
Novo Nordisk A/S,
Norgine B.V.
Scope and Context
Overview of the Parent Market
Analyst View

Market Size and Growth

North America (U.S., Canada)
Latin America (Mexico, Brazil, Rest of Latin America)
Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe)
Asia-Pacific (China, India, Singapore, Japan, Australia & New Zealand & Rest of Asia)
Rest of World
Segmentation
By Product Type
By End User
By Region
Market Dynamics
Supply & Demand Risk
Competitive Landscape
Porter’s Five Force Model
Geographical Economic Activity
Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio
Recent Trends and Developments
Industry Growth Drivers and Challenges
Key Information for Players to establish themselves in current dynamic environment

Request Buy Now: https://www.researchnester.com/payment/rep-id-23

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

For Table of Content & Free Sample Report Contact:
Name:-Ajay Daniel
Email: ajay.daniel@researchnester.com
U.S. +1 646 586 9123
U.K. +44 203 608 5919
Website:-www.researchnester.com

This release was published on openPR.